Codeine to stay OTC for now

A decision on whether to up-schedule codeine-based medicines has been delayed until at least 2017 because of the high number of submissions received during the consultation process.

The deferral will allow more thorough consideration of the submissions and the subsequent information provided, the TGA says.

The extra time will allow it to seek further